Dana-Farber Cancer Research, Teaching Affiliate, Harvard Medical School
World's First Antibody Targeting B7H7 Approved For Clinical Trial In The Us
Newly Approved Targeted Drug Makes 79% Of Patients' Tumours Disappear Altogether, This Type Of Blood Tumour Is Saved!
The "hand speed" is extremely fast, and scientists create a DNA robot arm that can move at a high speed
Imperial College Hospital
Study Shows Drug Halves Recurrence Rate In Patients With Early-Stage EGFR-Mutated Lung Cancer!
